SCHEMBL25867853

SCHEMBL25867853

CC(C)c1nccn1I

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24152748 0.82
SCHEMBL28079201 0.76
SCHEMBL48851 0.73
SCHEMBL28852577 0.71
SCHEMBL18445851 0.71
Fluoride SCHEMBL27856600 0.71 KDM4E (0.48)
SCHEMBL4529479 0.71
SCHEMBL3740454 0.71 SMN1; SMN2 (0.41)
SCHEMBL21872285 0.71 SMN1; SMN2 (0.53)
Hydrochloric Acid SCHEMBL1485396 0.70 SMN1; SMN2 (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230227499-A1 PRODRUGS OF MITOCHONDRIA-TARGETING OLIGOPEPTIDES STEALTH BIOTHERAPEUTICS INC. 2023-07-20 US disclosed
CN-106061963-B Heterocyclic modulators of lipid synthesis and combinations thereof 3-V生物科学股份有限公司 2019-10-22 CN disclosed
CN-109789132-A For treating double leucine zippers (DLK) kinase inhibitor of disease 德州大学系统董事会 2019-05-21 CN disclosed
CN-101568542-B 5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine derivatives ACTELION PHARMACEUTICALS LTD 2013-03-27 CN disclosed
CN-101568542-A 5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine derivatives ACTELION PHARMACEUTICALS LTD (CH) 2009-10-28 CN disclosed